As of May 29
| -2.18 / -1.76%|
The 7 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 114.00, with a high estimate of 132.00 and a low estimate of 85.00. The median estimate represents a -6.57% decrease from the last price of 122.02.
The current consensus among 9 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.